Engineering of the LAMP-CRISPR/Cas12b platform for Chlamydia psittaci detection
Journal of Medical Microbiology · 2023
DOI: 10.1099/jmm.0.001781 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2023. Verfasst von Rong Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, PR China. Hauptthemen laut MEDLINE: Chlamydophila psittaci, Psittacosis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Young Talent Development Plan of Changzhou Health Commission, Zhejiang Provincial Ten Thousand Plan for Young Top Talents, Key Laboratory Project of Changzhou City.
Abstract (Originalsprache)
Introduction
Chlamydia psittaci ( C. psittaci ) is a zoonotic infection, that causes psittacosis (parrot fever) in humans, leading to severe clinical manifestations, including severe pneumonia, adult respiratory distress syndrome, and, in rare cases, death. Gap Statement . Rapid, sensitive and specific detection of C. psittaci facilitates timely diagnosis and treatment of patients.
Aim
This study aimed to engineer the LAMP-CRISPR/Cas12b platform for C. psittaci detection. Methodology . The loop-mediated isothermal amplification (LAMP) technique and clustered regularly interspaced short palindromic repeats-CRISPR associated protein 12b (CRISPR-Cas12b) assay were combined to establish two-step and one-tube LAMP-CRISPR/Cas12b reaction systems, respectively, for rapidly detecting C. psittaci .
Results
The two-step and one-tube LAMP-CRISPR/Cas12b assay could complete detection within 1 h. No cross-reactivity was observed from non- C. psittaci templates with specific LAMP amplification primers and single-guide RNA (sgRNA) targeting the highly conserved short fragment CPSIT_0429 gene of C. psittaci . The detection limits of the two-step and one-tube LAMP-CRISPR/Cas12b reaction were 10 2 aM and 10 3 aM, respectively. The results were consistent with qPCR for nucleic acid detection in 160 clinical samples, including 80 suspected C. psittaci samples, kept in the laboratory.
Conclusions
The LAMP-CRISPR/Cas12b assay developed in this study provides a sensitive and specific method for rapidly detecting C. psittaci and offers technical support for its rapid diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, PR China.
- Pathogen Inspection Center, Changzhou Center for Disease Prevention and Control, Changzhou, Jiangsu 213022, PR China.
Förderung
- Young Talent Development Plan of Changzhou Health Commission
- Zhejiang Provincial Ten Thousand Plan for Young Top Talents
- Key Laboratory Project of Changzhou City
- Leading Talent of Changzhou “The 14th Five-Year Plan” High-Level Health Talents Training Project
- Changzhou Science and Technology Plan Project
- Key Research and Development Project of Jiangsu Province
Zitieren
APA
Wang, R., Mao, X., Xu, J., Yao, P., Jiang, J., Li, Q., & Wang, F. (2023). Engineering of the LAMP-CRISPR/Cas12b platform for Chlamydia psittaci detection. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.001781
Vancouver
Wang R, Mao X, Xu J, Yao P, Jiang J, Li Q, et al. Engineering of the LAMP-CRISPR/Cas12b platform for Chlamydia psittaci detection. Journal of Medical Microbiology. 2023. doi:10.1099/jmm.0.001781
BibTeX
@article{Wang2023,
author = {Wang, Rong and Mao, Xujian and Xu, Jian and Yao, Ping and Jiang, Jingyi and Li, Qiong and Wang, Fengming},
title = {Engineering of the LAMP-CRISPR/Cas12b platform for Chlamydia psittaci detection},
journal = {Journal of Medical Microbiology},
year = {2023},
doi = {10.1099/jmm.0.001781}
}
EUVIMED